Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis

Secukinumab improves scalp pain, itching, scaling and quality of life in patients with moderate-to-severe scalp psoriasis

Introduction: Scalp psoriasis adversely affects patients’ lives and is often resistant to treatment; however, it has not been a major focus of a clinical study. This analysis assessed the effect of secukinumab on patient-reported outcomes (PRO) of scalp psoriasis. Methods: A randomized, double-blind...

Full description

Bibliographic Details
Main Authors: Steven R. Feldman, Lawrence Green, Alexa B. Kimball, Kimberly Siu, Yang Zhao, Vivian Herrera, Judit Nyirady, Andrew F. Alexis
Format: Article
Language:English
Published: Taylor & Francis Group 2017-11-01
Series:Journal of Dermatological Treatment
Subjects:
scalp psoriasis
secukinumab
symptoms
patient-reported outcomes
itching
pain
scaling
Online Access:http://dx.doi.org/10.1080/09546634.2017.1329502

Internet

http://dx.doi.org/10.1080/09546634.2017.1329502

Similar Items